Evidence map›Paper›PMID 34721387›Full record

ArticleFrontiers in immunology2021

Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis.

Esther Ndungo, Liana R Andronescu, Andrea G Buchwald, Jose M Lemme-Dumit, Patricia Mawindo, Neeraj Kapoor, Jeff Fairman, Miriam K Laufer, Marcela F Pasetti

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. mBio · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. IgG Serum Antibodies toVaccines · 2024
    Article
  9. Oral immunization withmSphere · 2024
    Article
  10. Article
  11. Article
  12. Age-dependent acquisition of IgG antibodies toFrontiers in immunology · 2024
    Article
  13. Article
  14. A NovelmSphere · 2023
    Article
  15. Functional assays to evaluate antibody-mediated responses againstFrontiers in cellular and infection microbiology · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Esther NdungoDepartment of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Liana R AndronescuDepartment of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Andrea G BuchwaldDepartment of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Jose M Lemme-DumitDepartment of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Patricia MawindoBlantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi.
Neeraj KapoorVaxcyte Inc., Foster City, CA, United States.
Jeff FairmanVaxcyte Inc., Foster City, CA, United States.
Miriam K LauferDepartment of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
Marcela F PasettiDepartment of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.
University of Maryland, Baltimore · USEpitaxial Technologies (United States) · USUniversity of Malawi · MW

Funding

Research Training in Gastroenterology and HepatologyT32DK067872 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2024
$7.2M
Serological assays to predict Shigella vaccine efficacyR01AI125841 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PASETTI, MARCELA F · 2016 to 2020
$2.8M
Vaccines and maternally acquired immunity to prevent shigellosis in childrenR01AI117734 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PASETTI, MARCELA F · 2015 to 2019
$2.0M
Mentoring in patient-oriented research in global healthK24AI114996 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI LAUFER, MIRIAM K. · 2016 to 2025
$1.6M
NIAID NIH HHS K24 AI114996NIAID NIH HHS R01 AI117734NIAID NIH HHS R01 AI125841NIDDK NIH HHS T32 DK067872
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAntibodies, BacterialCohort StudiesDysentery, BacillaryFemaleHumansImmunity, Maternally-AcquiredImmunoglobulin GInfantInfant, NewbornMalawiMalePregnancyShigella flexneriShigella VaccinesAntibodies, BacterialImmunoglobulin GShigella Vaccinesinfant immunitymaternal antibodiesnaturally acquired immunityShigella antibodiestransplacental antibody transfer

Identifiers

PMID34721387
PMCPMC8554191
OpenAlexW3206210767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.